Commentary Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.33696/AIDS.3.016
Commentary on Lahiri et al. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV
Francesca Macaluso1, Deborah R. Gustafson2,*
- 1Department of Medicine, State University of New York at Downstate Health Sciences University, Brooklyn NY, United States
- 2Professor, Department of Neurology, Section for NeuroEpidemiology, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA
Corresponding Author
Deborah R. Gustafson, deborah.gustafson@downstate.edu
Received Date: February 04, 2021
Accepted Date: March 26, 2021
Citation:
Macaluso F, Gustafson DR. Commentary on Lahiri et al. Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV. J AIDS HIV Treat. 2021; 3(2): 21-23.
Copyright: © 2021 Macaluso F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.